Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koç, O. N.
Right arrow Articles by Lazarus, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koç, O. N.
Right arrow Articles by Lazarus, H. M.
Journal of Clinical Oncology, Vol 18, Issue 2 (January), 2000: 307
© 2000 American Society for Clinical Oncology

Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy

By Omer N. Koç, Stanton L. Gerson, Brenda W. Cooper, Stephanie M. Dyhouse, Stephen E. Haynesworth, Arnold I. Caplan, Hillard M. Lazarus

From the Departments of Medicine and Biology, Case Western Reserve University; and Division of Hematology/Oncology and Ireland Cancer Center of University Hospitals of Cleveland, Cleveland, OH.

Address reprint requests to Omer N. Koç, MD, Case Western Reserve University, BRB-3 Hematology/Oncology, 10900 Euclid Ave, Cleveland OH 44106; email onk2{at}po.cwru.edu

PURPOSE: Multipotential mesenchymal stem cells (MSCs) are found in human bone marrow and are shown to secrete hematopoietic cytokines and support hematopoietic progenitors in vitro. We hypothesized that infusion of autologous MSCs after myeloablative therapy would facilitate engraftment by hematopoietic stem cells, and we investigated the feasibility, safety, and hematopoietic effects of culture-expanded MSCs in breast cancer patients receiving autologous peripheral-blood progenitor-cell (PBPC) infusion.

PATIENTS AND METHODS: We developed an efficient method of isolating and culture-expanding a homogenous population of MSCs from a small marrow-aspirate sample obtained from 32 breast cancer patients. Twenty-eight patients were given high-dose chemotherapy and autologous PBPCs plus culture-expanded MSC infusion and daily granulocyte colony-stimulating factor.

RESULTS: Human MSCs were successfully isolated from a mean ± SD of 23.4 ± 5.9 mL of bone marrow aspirate from all patients. Expansion cultures generated greater than 1 x 106 MSCs/kg for all patients over 20 to 50 days with a mean potential of 5.6 to 36.3 x 106 MSCs/kg after two to six passages, respectively. Twenty-eight patients were infused with 1 to 2.2 x 106 expanded autologous MSCs/kg intravenously over 15 minutes. There were no toxicities related to the infusion of MSCs. Clonogenic MSCs were detected in venous blood up to 1 hour after infusion in 13 of 21 patients (62%). Median time to achieve a neutrophil count greater than 500/µL and platelet count >= 20,000/µL untransfused was 8 days (range, 6 to 11 days) and 8.5 days (range, 4 to 19 days), respectively.

CONCLUSION: This report is the first describing infusion of autologous MSCs with therapeutic intent. We found that autologous MSC infusion at the time of PBPC transplantation is feasible and safe. The observed rapid hematopoietic recovery suggests that MSC infusion after myeloablative therapy may have a positive impact on hematopoiesis and should be tested in randomized trials.




This article has been cited by other articles:


Home page
 Stem CellsHome page
V. Fritz, D. Noel, C. Bouquet, P. Opolon, R. Voide, F. Apparailly, P. Louis-Plence, C. Bouffi, H. Drissi, C. Xie, et al.
Antitumoral Activity and Osteogenic Potential of Mesenchymal Stem Cells Expressing the Urokinase-Type Plasminogen Antagonist Amino-Terminal Fragment in a Murine Model of Osteolytic Tumor
Stem Cells, November 1, 2008; 26(11): 2981 - 2990.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
C. Ren, S. Kumar, D. Chanda, J. Chen, J. D. Mountz, and S. Ponnazhagan
Therapeutic Potential of Mesenchymal Stem Cells Producing Interferon-{alpha} in a Mouse Melanoma Lung Metastasis Model
Stem Cells, September 1, 2008; 26(9): 2332 - 2338.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
Z. Lee, J. E. Dennis, and S. L. Gerson
Imaging Stem Cell Implant for Cellular-Based Therapies
Experimental Biology and Medicine, August 1, 2008; 233(8): 930 - 940.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. H. Moon, J. R. Lee, B. C. Jee, C. S. Suh, S. H. Kim, H. J. Lim, and H. K. Kim
Successful vitrification of human amnion-derived mesenchymal stem cells
Hum. Reprod., August 1, 2008; 23(8): 1760 - 1770.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. K. Rebelatto, A. M. Aguiar, M. P. Moretao, A. C. Senegaglia, P. Hansen, F. Barchiki, J. Oliveira, J. Martins, C. Kuligovski, F. Mansur, et al.
Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue
Experimental Biology and Medicine, July 1, 2008; 233(7): 901 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Eliopoulos, M. Francois, M.-N. Boivin, D. Martineau, and J. Galipeau
Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Cancer Res., June 15, 2008; 68(12): 4810 - 4818.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
G. Lazennec and C. Jorgensen
Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
Stem Cells, June 1, 2008; 26(6): 1387 - 1394.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
F. Morandi, L. Raffaghello, G. Bianchi, F. Meloni, A. Salis, E. Millo, S. Ferrone, V. Barnaba, and V. Pistoia
Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens
Stem Cells, May 1, 2008; 26(5): 1275 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
N. Sessarego, A. Parodi, M. Podesta, F. Benvenuto, M. Mogni, V. Raviolo, M. Lituania, A. Kunkl, G. Ferlazzo, F. D. Bricarelli, et al.
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application
Haematologica, March 1, 2008; 93(3): 339 - 346.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Sasaki, R. Abe, Y. Fujita, S. Ando, D. Inokuma, and H. Shimizu
Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type
J. Immunol., February 15, 2008; 180(4): 2581 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
X.-Y. Wang, Y. Lan, W.-Y. He, L. Zhang, H.-Y. Yao, C.-M. Hou, Y. Tong, Y.-L. Liu, G. Yang, X.-D. Liu, et al.
Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos
Blood, February 15, 2008; 111(4): 2436 - 2443.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
E. Traggiai, S. Volpi, F. Schena, M. Gattorno, F. Ferlito, L. Moretta, and A. Martini
Bone Marrow-Derived Mesenchymal Stem Cells Induce Both Polyclonal Expansion and Differentiation of B Cells Isolated from Healthy Donors and Systemic Lupus Erythematosus Patients
Stem Cells, February 1, 2008; 26(2): 562 - 569.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
E. Jones and D. McGonagle
Human bone marrow mesenchymal stem cells in vivo
Rheumatology, February 1, 2008; 47(2): 126 - 131.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Blood, February 1, 2008; 111(3): 1327 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
N. Meuleman, G. Vanhaelen, T. Tondreau, P. Lewalle, J. Kwan, J. Bennani, P. Martiat, L. Lagneaux, and D. Bron
Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report
Haematologica, January 1, 2008; 93(1): e11 - e13.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
Z. Love, F. Wang, J. Dennis, A. Awadallah, N. Salem, Y. Lin, A. Weisenberger, S. Majewski, S. Gerson, and Z. Lee
Imaging of Mesenchymal Stem Cell Transplant by Bioluminescence and PET
J. Nucl. Med., December 1, 2007; 48(12): 2011 - 2020.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
I. A. Isakova, K. Baker, M. DuTreil, J. Dufour, D. Gaupp, and D. G. Phinney
Age- and Dose-Related Effects on MSC Engraftment Levels and Anatomical Distribution in the Central Nervous Systems of Nonhuman Primates: Identification of Novel MSC Subpopulations That Respond to Guidance Cues in Brain
Stem Cells, December 1, 2007; 25(12): 3261 - 3270.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. J. Nauta and W. E. Fibbe
Immunomodulatory properties of mesenchymal stromal cells
Blood, November 15, 2007; 110(10): 3499 - 3506.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. E. Bernardo, N. Zaffaroni, F. Novara, A. M. Cometa, M. A. Avanzini, A. Moretta, D. Montagna, R. Maccario, R. Villa, M. G. Daidone, et al.
Human Bone Marrow Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term In vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms
Cancer Res., October 1, 2007; 67(19): 9142 - 9149.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Zhang, N. Mal, M. Kiedrowski, M. Chacko, A. T. Askari, Z. B. Popovic, O. N. Koc, and M. S. Penn
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction
FASEB J, October 1, 2007; 21(12): 3197 - 3207.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. A. Cahill, D. Wenkert, S. A. Perlman, A. Steele, S. P. Coburn, W. H. McAlister, S. Mumm, and M. P. Whyte
Infantile Hypophosphatasia: Transplantation Therapy Trial Using Bone Fragments and Cultured Osteoblasts
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2923 - 2930.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
F. Locatelli, R. Maccario, and F. Frassoni
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?
Haematologica, July 1, 2007; 92(7): 872 - 877.
[Full Text] [PDF]

Home page
 haematolHome page
M. Shi, J. Li, L. Liao, B. Chen, B. Li, L. Chen, H. Jia, and R. C. Zhao
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice
Haematologica, July 1, 2007; 92(7): 897 - 904.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech
The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities
Stem Cells, July 1, 2007; 25(7): 1737 - 1745.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. Rao
Introducing a New Stem Cells Series
Stem Cells, July 1, 2007; 25(7): 1602 - 1602.
[Full Text] [PDF]

Home page
 Stem CellsHome page
A. Kocaoemer, S. Kern, H. Kluter, and K. Bieback
Human AB Serum and Thrombin-Activated Platelet-Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue
Stem Cells, May 1, 2007; 25(5): 1270 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines
Blood, May 1, 2007; 109(9): 4055 - 4063.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
A. De Becker, P. Van Hummelen, M. Bakkus, I. Vande Broek, J. De Wever, M. De Waele, and I. Van Riet
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3
Haematologica, April 1, 2007; 92(4): 440 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
A. Hernando Insua, A. D. Montaner, J. M. Rodriguez, F. Elias, J. Flo, R. A. Lopez, J. Zorzopulos, E. L. Hofer, and N. A. Chasseing
IMT504, the Prototype of the Immunostimulatory Oligonucleotides of the PyNTTTTGT Class, Increases the Number of Progenitors of Mesenchymal Stem Cells Both In Vitro and In Vivo: Potential Use in Tissue Repair Therapy
Stem Cells, April 1, 2007; 25(4): 1047 - 1054.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Gottschling, R. Saffrich, A. Seckinger, U. Krause, K. Horsch, K. Miesala, and A. D. Ho
Human Mesenchymal Stromal Cells Regulate Initial Self-Renewing Divisions of Hematopoietic Progenitor Cells by a {beta}1-Integrin-Dependent Mechanism
Stem Cells, March 1, 2007; 25(3): 798 - 806.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. J. Gang, D. Bosnakovski, C. A. Figueiredo, J. W. Visser, and R. C. R. Perlingeiro
SSEA-4 identifies mesenchymal stem cells from bone marrow
Blood, February 15, 2007; 109(4): 1743 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
L. Sun, H. Zhang, X. Feng, Y. Hou, L. Lu, and L. Fan
Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus
Lupus, February 1, 2007; 16(2): 121 - 128.
[Abstract] [PDF]

Home page
 haematolHome page
M. Drouet, J.-F. Mayol, F. Norol, A. Peinnequin, J.-P. Zarski, C. Letoublon, and F. Herodin
Lack of evidence of sustained hematopoietic reconstitution after transplantation of unmanipulated adult liver stem cells in monkeys
Haematologica, February 1, 2007; 92(2): 248 - 251.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. L. Chan, M. Choi, S. Wnendt, M. Kraus, E. Teng, H. F. Leong, and S. Merchav
Enhanced In Vivo Homing of Uncultured and Selectively Amplified Cord Blood CD34+ Cells by Cotransplantation with Cord Blood-Derived Unrestricted Somatic Stem Cells
Stem Cells, February 1, 2007; 25(2): 529 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
Q. He, C. Wan, and G. Li
Concise Review: Multipotent Mesenchymal Stromal Cells in Blood
Stem Cells, January 1, 2007; 25(1): 69 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
T. E. Meyerrose, D. A. De Ugarte, A. A. Hofling, P. E. Herrbrich, T. D. Cordonnier, L. D. Shultz, J. C. Eagon, L. Wirthlin, M. S. Sands, M. A. Hedrick, et al.
In Vivo Distribution of Human Adipose-Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models
Stem Cells, January 1, 2007; 25(1): 220 - 227.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Blood, January 1, 2007; 109(1): 228 - 234.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. G. Berger, R. Veyrat-Masson, C. Rapatel, S. Descamps, J. Chassagne, and N. Boiret-Dupre
Cell Culture Medium Composition and Translational Adult Bone Marrow-Derived Stem Cell Research
Stem Cells, December 1, 2006; 24(12): 2888 - 2890.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Ruster, S. Gottig, R. J. Ludwig, R. Bistrian, S. Muller, E. Seifried, J. Gille, and R. Henschler
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
Blood, December 1, 2006; 108(12): 3938 - 3944.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
C.-J. Chang, M.-L. Yen, Y.-C. Chen, C.-C. Chien, H.-I. Huang, C.-H. Bai, and B. L. Yen
Placenta-Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon-{gamma}
Stem Cells, November 1, 2006; 24(11): 2466 - 2477.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. M. van Laar and A. Tyndall
Adult stem cells in the treatment of autoimmune diseases
Rheumatology, October 1, 2006; 45(10): 1187 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. J. Nauta, G. Westerhuis, A. B. Kruisselbrink, E. G. A. Lurvink, R. Willemze, and W. E. Fibbe
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Blood, September 15, 2006; 108(6): 2114 - 2120.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
X. Chen, H. Xu, C. Wan, M. McCaigue, and G. Li
Bioreactor Expansion of Human Adult Bone Marrow-Derived Mesenchymal Stem Cells
Stem Cells, September 1, 2006; 24(9): 2052 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Sudres, F. Norol, A. Trenado, S. Gregoire, F. Charlotte, B. Levacher, J.-J. Lataillade, P. Bourin, X. Holy, J.-P. Vernant, et al.
Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice.
J. Immunol., June 15, 2006; 176(12): 7761 - 7767.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
B.-R. Son, L. A. Marquez-Curtis, M. Kucia, M. Wysoczynski, A. R. Turner, J. Ratajczak, M. Z. Ratajczak, and A. Janowska-Wieczorek
Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal-Derived Factor-1-CXCR4 and Hepatocyte Growth Factor-c-met Axes and Involves Matrix Metalloproteinases
Stem Cells, May 1, 2006; 24(5): 1254 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail
Cell Culture Medium Composition and Translational Adult Bone Marrow-Derived Stem Cell Research
Stem Cells, May 1, 2006; 24(5): 1409 - 1410.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. Honczarenko, Y. Le, M. Swierkowski, I. Ghiran, A. M. Glodek, and L. E. Silberstein
Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors
Stem Cells, April 1, 2006; 24(4): 1030 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau
Interferon-{gamma}-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Blood, March 15, 2006; 107(6): 2570 - 2577.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Muguruma, T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando
Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment
Blood, March 1, 2006; 107(5): 1878 - 1887.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
Blood, February 15, 2006; 107(4): 1484 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. Aluigi, M. Fogli, A. Curti, A. Isidori, E. Gruppioni, C. Chiodoni, M. P. Colombo, P. Versura, A. D'Errico-Grigioni, E. Ferri, et al.
Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow-Derived Mesenchymal Stem Cells
Stem Cells, February 1, 2006; 24(2): 454 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail
Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells
Stem Cells, February 1, 2006; 24(2): 462 - 471.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
M. Krampera, L. Cosmi, R. Angeli, A. Pasini, F. Liotta, A. Andreini, V. Santarlasci, B. Mazzinghi, G. Pizzolo, F. Vinante, et al.
Role for Interferon-{gamma} in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells
Stem Cells, February 1, 2006; 24(2): 386 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. J. Minguell and A. Erices
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49.
[Abstract] [Full Text] [PDF]

Home page